Promeditech SRL
The score of Promeditech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -7 % Total assets -3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Promeditech's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
Promeditech's financial analysis
- Solvency42.4%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Promeditech
Promeditech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0807.225.387
- VAT number
- BE0807225387
- Peppol
- Registered · 0208:0807225387 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Oct 2008
- Registered office
- 1130 Brussels
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Promeditech (SRL) has been based in Brussels since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 2,011 € and equity of 79,227 €; its revenue is not published. Its solvency stands at 42.4%, above the median of its sector (37.6%).
Companies similar to Promeditech
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DES Viaducs Retail sale of pharmaceutical products Mons · balance sheet 97,079 €
- Apotheek Baert S. Retail sale of pharmaceutical products Bruges · balance sheet 194,387 €
- BMVA Retail sale of pharmaceutical products Bornem · balance sheet 167,342 €
- Sentelys Pharma Retail sale of pharmaceutical products Koekelberg · balance sheet 225,328 €
- Babay Pharma Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 246,996 €
- SOBEN Pharma Robeerst Retail sale of pharmaceutical products Esneux · balance sheet 282,954 €
- Apoteek Lefever-Feyaerts Retail sale of pharmaceutical products Overijse · balance sheet 283,638 €
- Zorgapotheek Maldegem Retail sale of pharmaceutical products Maldegem · balance sheet 304,353 €
Frequently asked questions about Promeditech
What is the revenue of Promeditech?
Promeditech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Promeditech?
In Belgium, the VAT number is the company number prefixed with BE: BE0807225387 for Promeditech, if the company is VAT-registered. Its company number (CBE) is 0807.225.387.
Where is the registered office of Promeditech?
According to the CBE register, the registered office of Promeditech is in 1130 Brussels.
What is the equity of Promeditech?
At the close of the 2025 financial year, the equity of Promeditech amounts to 79,227 €, a solvency of 42.4% of total assets.
Who manages Promeditech?
The register lists 1 active mandates at Promeditech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Promeditech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →